D&D Pharmatech Inc. research brief
CIK 2077939
Generated Nov. 19, 2026, 11:11 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: SEONGNAM-SI Korea, Republic Of. Reported legal jurisdiction: KOREA, REPUBLIC OF. These do not establish investor residence or where funds were deployed.
- Aug. 1, 2025 · D · 0002077939-25-000001 · Source evidence
Reported offering amount: 10800000 USD. Reported amount sold: 10800000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “D&D Pharmatech Inc. research brief,” CIK 2077939, retrieved Nov. 19, 2026, 11:11 a.m.. Cite the specific accessions used. No amounts have been summed.